Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Gains from Sales and Divestitures: 2024

Historic Gains from Sales and Divestitures for Zenas BioPharma (ZBIO) over the last 1 years, with Dec 2024 value amounting to $6,028.

  • Zenas BioPharma's Gains from Sales and Divestitures was N/A to $6,028 in Q4 2024 from the same period last year, while for Dec 2024 it was $6,028, marking a year-over-year change of. This contributed to the annual value of $6,028 for FY2024, which is N/A change from last year.
  • Latest data reveals that Zenas BioPharma reported Gains from Sales and Divestitures of $6,028 as of FY2024.
  • Zenas BioPharma's 5-year Gains from Sales and Divestitures high stood at $6,028 for FY2024, and its period low was $6,028 during FY2024.
  • In the last 1 years, Zenas BioPharma's Gains from Sales and Divestitures had a median value of $6,028 in 2024 and averaged $6,028.